In this setting, ML model analysis on preoperative MRI images resulted in promising performances for predicting IDH mutation, MGMT methylation, and 1p/19q codeletion in glioma, considering the role of these key metabolic features in the differential diagnosis of brain tumors, with potential translational diagnostic and therapeutic impact [29]. This evidence concerns the gene MGMT and glioma.